Latest news
Oculis Holding (OCS) inks $3.8M cash-plus-shares deal for Privosegtor rights - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:34 GMTOculis (NASDAQ: OCS) pivots to neuro-ophthalmology as H1 loss falls - Stock TitanStock Titan · Thu, 06 Aug 2026 20:17:00 GMTFDA Says Oculis Can Cross-Reference Data for Planned MS Relapse Trial - Stock TitanStock Titan · Mon, 03 Aug 2026 08:00:00 GMT